Revenue from contracts with customers

3 Months Ended

Mar. 31, 2025

Revenue from Contract with Customer [Abstract]

Revenue from contracts with customers

Note 4 – Revenue from contracts with customers

Disaggregated revenue

The Company provides listing sponsorship and consulting services to growth-stage private companies and, prior to its repositioning, the Company provided diagnostic test products and laboratory services to hospitals, clinical laboratories and other healthcare providing customers. The revenues by type of service consist of the following:

	Three Months Ended March 31,
	2025		2024
Product sales	$	-	$	141,373
Laboratory services		-		26,776
Listing sponsorship services		-		-
Total revenue	$	-	$	168,149

Revenues by geography are as follows:

	Three Months Ended March 31,
	2025		2024
Domestic	$	-	$	168,149
International		-		-
Total revenue	$	-	$	168,149

Deferred revenue

Changes in deferred revenue for the three months ended March 31, 2024 were as follows:

Balance at December 31, 2023	$	25,926
Recognized		(12,525	)
Refunded to customers		(4,830	)
Balance at March 31, 2024	$	8,571